Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 82,760,696
- Share change
- +694,298
- Total reported value
- $429,420,057
- Put/Call ratio
- 131%
- Price per share
- $5.19
- Number of holders
- 197
- Value change
- +$74,534,872
- Number of buys
- 107
- Number of sells
- 92
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
13%
|
13,938,589
|
$35,822,174 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13D/G
13F
|
Company |
4.6%
|
4,784,658
|
$23,617,550 | $0 | 30 Sep 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
8,565,317
|
$22,012,866 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
5,994,459
|
$15,405,760 | — | 30 Jun 2024 | |
| Palo Alto Investors LP |
13F
13D/G
|
Company · Patrick Lee, MD |
1.5%
from 13D/G
|
5,257,086
|
$13,510,711 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
3.4%
|
3,567,139
|
$9,167,547 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.8%
|
2,944,861
|
$7,568,292 | — | 30 Jun 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
2.7%
|
2,800,000
|
$7,196,000 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
2.5%
|
2,656,847
|
$6,828,097 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,297,965
|
$5,907,129 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,283,640
|
$5,868,955 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.1%
|
2,237,505
|
$5,750,388 | — | 30 Jun 2024 | |
| Aubrey Rankin |
3/4/5
|
Director |
—
class O/S missing
|
570,004
|
$4,257,930 | — | 15 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
1,056,062
|
$2,714,080 | — | 30 Jun 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.98%
|
1,023,663
|
$2,630,814 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.93%
|
977,095
|
$2,511,135 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.89%
|
933,618
|
$2,399,398 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.83%
|
866,186
|
$2,226,098 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.72%
|
756,912
|
$1,945,264 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
749,587
|
$1,926,439 | — | 30 Jun 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.68%
|
712,072
|
$1,830,025 | — | 30 Jun 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.67%
|
701,707
|
$1,803,387 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.61%
|
633,903
|
$1,629,131 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.58%
|
610,792
|
$1,569,735 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.57%
|
600,000
|
$1,542,000 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.55%
|
572,000
|
$1,470,040 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.51%
|
535,387
|
$1,376,000 | — | 30 Jun 2024 | |
| EULAV Asset Management |
13F
|
Company |
0.48%
|
500,000
|
$1,285,000 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.48%
|
500,000
|
$1,285,000 | — | 30 Jun 2024 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
0.44%
|
457,085
|
$1,174,708 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.42%
|
441,584
|
$1,135,000 | — | 30 Jun 2024 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.4%
|
417,161
|
$1,072,104 | — | 30 Jun 2024 | |
| CM Management, LLC |
13F
|
Company |
0.38%
|
400,000
|
$1,028,000 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
400,000
|
$1,028,000 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.36%
|
373,015
|
$958,649 | — | 30 Jun 2024 | |
| Abhay Joshi |
3/4/5
|
COO, President of R&D |
—
class O/S missing
|
120,708
|
$901,689 | — | 15 Mar 2022 | |
| Dustin S. Sjuts |
3/4/5
|
President |
—
class O/S missing
|
167,550
|
$844,871 | — | 15 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.31%
|
325,314
|
$836,057 | — | 30 Jun 2024 | |
| Lane Generational LLC |
13F
|
Company |
0.31%
|
319,322
|
$820,658 | — | 30 Jun 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.28%
|
290,515
|
$746,622 | — | 30 Jun 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.24%
|
250,000
|
$642,500 | — | 30 Jun 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.24%
|
250,000
|
$642,500 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.24%
|
249,029
|
$640,005 | — | 30 Jun 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.23%
|
245,000
|
$629,650 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.23%
|
237,790
|
$611,120 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.21%
|
225,000
|
$578,250 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
201,080
|
$516,775 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.19%
|
198,846
|
$511,034 | — | 30 Jun 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.19%
|
197,049
|
$506,416 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.19%
|
194,650
|
$500,251 | — | 30 Jun 2024 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q3 2024
As of 30 Sep 2024,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,760,696 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, FIL Ltd, ALPINE ASSOCIATES MANAGEMENT INC., ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, and WATER ISLAND CAPITAL LLC.
This page lists
198
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
167
Q3 2024 holders
197
Holder diff
30
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.